Evidence map›Paper›PMID 33874930›Full record

ArticleBMC pulmonary medicine2021

Patent foramen ovale revealed by COVID-19 pneumonia.

Charlotte Vanhomwegen, Olivier Taton, Nicolas Selvais, Olivier Vanhove, Dimitri Leduc

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charlotte VanhomwegenCHU Erasme Hospital, Université Libre de Bruxelles, Route de Lennick 808, 1070, Brussels, Belgium. cvhomweg@gmail.com.ORCID http://orcid.org/0000-0001-5853-8717
Olivier TatonDepartment of Pneumology, CHU Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.
Nicolas SelvaisDepartment of Cardiology, CHU Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.
Olivier VanhoveDepartment of Pneumology, CHU Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.ORCID http://orcid.org/0000-0002-0756-0399
Dimitri LeducDepartment of Pneumology, CHU Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlatypnea-orthodeoxia syndrome (POS) is a rare condition characterized by dyspnoea (platypnea) and arterial desaturation in the upright position resolved in the supine position (orthodeoxia). Intracardiac shunt, pulmonary ventilation-perfusion mismatch and others intrapulmonary abnormalities are involved. CASE PRESENTATION: We report a case of POS associated with two pathophysiological issues: one, cardiac POS caused by a patent foramen ovale (PFO) and second, pulmonary POS due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interstitial pneumonia. POS has resolved after recovery of coronavirus disease 2019 (COVID-19) pneumonia.

conclusionsRight-to-left interatrial shunt and intrapulmonary shunt caused by SARS-CoV-2 pneumonia contributed to refractory hypoxemia and POS. Therefore, in case of COVID-19 patient with unexplained POS, the existence of PFO must be investigated.

Indexed as

COVID-19DyspneaForamen Ovale, PatentHypoxiaPneumonia, ViralEchocardiographyHemodynamicsHumansLungLung Diseases, InterstitialMaleMiddle AgedOxygenPostureSARS-CoV-2SyndromeOxygenHypoxemiaPatent foramen ovalePulmonary vasoconstrictionSARS-CoV-2Ventilation inhomogeneity

Identifiers

PMID33874930
PMCPMC8054231
OpenAlexW3152613411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.